Ardent Health, Inc. (ARDT) Stock Analysis
Healthcare · Medical Care Facilities · NYSE
Ardent Health, Inc. (ARDT) posted $6.32B in revenue for fiscal 2025 (up 6.0% year over year), at a 2.1% net margin, and has compounded revenue about 7.2%/yr over five years, per its SEC filings.
Data last refreshed August 2, 2026 from SEC filings · how we compute this
The analyst's take on Ardent Health, Inc.
Ardent Health, Inc. has grown revenue from $5.13B to $6.32B over the last 4 fiscal years, compounding about 7.2% a year. The most recent year was up 6%, so growth has cooled from its longer-run pace.
Net margin sits at 2.1%, down 1.4 points year over year on a 40.9% gross margin. It carries about $1.10B of total debt.
At today's valuation the market is pricing in roughly -11.4% annual free-cash-flow growth.
Synthesised from Ardent Health, Inc.'s SEC filings — descriptive, not advice. Ask the analyst your own question →
Ardent Health, Inc. revenue & earnings — last 4 fiscal years
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $5.13B | $5.41B | $5.97B | $6.32B |
| Gross profit | $1.76B | $2.03B | $2.40B | $2.58B |
| Net income | $188.91M | $53.90M | $210.34M | $135.81M |
| Net margin | 3.7% | 1.0% | 3.5% | 2.1% |
Source: Ardent Health, Inc. SEC filings (10-K).
Ardent Health, Inc.: no obvious red flags in the filings
Our deterministic scan of the filed statements — receivables vs sales, earnings vs cash, dilution, leverage and margins — didn't flag anything. Ask about the risks →
What growth is priced into ARDT stock?
At today's market cap of $1.35B, Ardent Health, Inc. is priced for free-cash-flow growth of about -11.4% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $258.61M from the FY ending 2025-12-31). This is a reverse DCF — a translation of the price into a growth assumption you can judge, not a fair value and not advice. Change the assumptions yourself in the interactive view →
Explore 4 years of Ardent Health, Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track ARDT in your portfolio →
Ardent Health, Inc. financial history by metric
About Ardent Health, Inc.
Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women's services, neurology, urology, and emergency services within inpatient and ambulatory care settings. It also operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers, urgent care centers, free-standing emergency departments, and diagnostic imaging centers. The company operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. Ardent Health, Inc. was formerly known as Ardent Health Partners, Inc. and changed its name to Ardent Health, Inc. in June 2025. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health, Inc. is a subsidiary of EGI-AM Investments, L.L.C.
Ardent Health, Inc. — frequently asked questions
What is Ardent Health, Inc.'s revenue?
Ardent Health, Inc. (ARDT) reported revenue of $6.32B for fiscal year 2025, up 6.0% from the prior year, according to its SEC filings.
Is Ardent Health, Inc. profitable?
Yes. ARDT earned net income of $135.81M in fiscal 2025, a net margin of 2.1%.
What is ARDT's P/E ratio?
Ardent Health, Inc. trades at a price-to-earnings ratio of about 9.9 based on the latest data in our nightly-refreshed cache.
How fast is Ardent Health, Inc. growing?
ARDT's revenue grew at roughly 7.2% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does Ardent Health, Inc. have?
As of fiscal year 2025, ARDT carried roughly $1.10B in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is Ardent Health, Inc.'s gross margin?
ARDT's gross margin was 40.9% in fiscal 2025 — gross profit of $2.58B on revenue of $6.32B.
What is Ardent Health, Inc.'s market cap?
Ardent Health, Inc. (ARDT) has a market capitalization of about $1.35B, based on the latest data in our nightly-refreshed cache.
When does Ardent Health, Inc.'s fiscal year end?
ARDT's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
What growth is priced into ARDT stock?
At today's market cap of $1.35B, Ardent Health, Inc. is priced for free-cash-flow growth of about -11.4% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $258.61M from the FY ending 2025-12-31).
Where does this data come from?
All figures are computed from Ardent Health, Inc.'s official SEC filings (10-K and 10-Q), covering 4 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.